Evidence map›Paper›PMID 17204147›Full record

ReviewOrphanet journal of rare diseases2007

Hereditary chronic pancreatitis.

Jonas Rosendahl, Hans Bödeker, Joachim Mössner, Niels Teich

Open access · goldAbstract readReview
In one paragraph

Review in Orphanet journal of rare diseases, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
12.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 224 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. PRSS1 (R122H) mutation in an Indian family with low penetrance is associated with pancreatitis phenotype.Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology · 2018
    Article
  10. Review
  11. Observational
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Idiopathic chronic calcific pancreatitis in a child: An uncommon entity.Journal of natural science, biology, and medicine · 2013
    Article
  18. Genetic risk for alcoholic chronic pancreatitis.International journal of environmental research and public health · 2011
    Review
  19. Abdominal pain in a 5-year-old boy.BMJ case reports · 2011
    Article
  20. Acute pancreatitis complicated with choledochal duct rupture.Case reports in gastrointestinal medicine · 2011
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Jonas RosendahlMedizinische Klinik und Poliklinik II, Universität Leipzig, Germany. jonas.rosendahl@medizin.uni-leipzig.de
Hans Bödeker
Joachim Mössner
Niels Teich
Klinik und Poliklinik für Psychosomatische Medizin und Psychotherapie · DELeipzig University · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hereditary chronic pancreatitis (HCP) is a very rare form of early onset chronic pancreatitis. With the exception of the young age at diagnosis and a slower progression, the clinical course, morphological features and laboratory findings of HCP do not differ from those of patients with alcoholic chronic pancreatitis. As well, diagnostic criteria and treatment of HCP resemble that of chronic pancreatitis of other causes. The clinical presentation is highly variable and includes chronic abdominal pain, impairment of endocrine and exocrine pancreatic function, nausea and vomiting, maldigestion, diabetes, pseudocysts, bile duct and duodenal obstruction, and rarely pancreatic cancer. Fortunately, most patients have a mild disease. Mutations in the PRSS1 gene, encoding cationic trypsinogen, play a causative role in chronic pancreatitis. It has been shown that the PRSS1 mutations increase autocatalytic conversion of trypsinogen to active trypsin, and thus probably cause premature, intrapancreatic trypsinogen activation disturbing the intrapancreatic balance of proteases and their inhibitors. Other genes, such as the anionic trypsinogen (PRSS2), the serine protease inhibitor, Kazal type 1 (SPINK1) and the cystic fibrosis transmembrane conductance regulator (CFTR) have been found to be associated with chronic pancreatitis (idiopathic and hereditary) as well. Genetic testing should only be performed in carefully selected patients by direct DNA sequencing and antenatal diagnosis should not be encouraged. Treatment focuses on enzyme and nutritional supplementation, pain management, pancreatic diabetes, and local organ complications, such as pseudocysts, bile duct or duodenal obstruction. The disease course and prognosis of patients with HCP is unpredictable. Pancreatic cancer risk is elevated. Therefore, HCP patients should strongly avoid environmental risk factors for pancreatic cancer.

Indexed as

Genetic Predisposition to DiseaseAdultAnimalsCarrier ProteinsChildCystic FibrosisCystic Fibrosis Transmembrane Conductance RegulatorDatabases, GeneticDiagnosis, DifferentialDisease Models, AnimalGenetic CounselingGenetic TestingHumansMiceMutationPancreatic NeoplasmsCarrier ProteinsCFTR protein, humanCystic Fibrosis Transmembrane Conductance RegulatorPRSS2 protein, humanSPINK1 protein, humanTrypsinTrypsin Inhibitor, Kazal PancreaticTrypsinogen

Identifiers

PMID17204147
PMCPMC1774562
OpenAlexW1510555818

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.